Is this you? Create Your Porfile
Avatar

Sharat Singh

Duke University

Hotspot
Bubble
Bubble
[Coming Soon]
 Word Cloud
Cloud
 Mosaic Glass
Mosaic
[Coming Soon]

Archive | 2007

Methods of predicting and monitoring tyrosine kinase inhibitor therapy

Jeanne Harvey; Bruce Neri; Sharat Singh

Archive | 2008

Antibody-based arrays for detecting multiple signal transducers in rare circulating cells

Jeanne Harvey; Sharat Singh; Phillip Kim; Xinjun Liu; Robert Barham; Limin Liu

Archive | 2010

Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy

Phillip Kim; Xinjun Liu; Richard Kirkland; Tani Lee; Belen Ybarrondo; Sharat Singh

Archive | 2010

PROXIMITY-MEDIATED ASSAYS FOR DETECTING ONCOGENIC FUSION PROTEINS

Sharat Singh; Xinjun Liu

Archive | 2013

Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies

Sharat Singh; Scott Hauenstein; Linda Ohrmund

Archive | 2011

Methods for predicting response of triple-negative breast cancer to therapy

Xinjun Liu; Phillip Kim; Richard Kirkland; Tani Lee; Belen Ybarrondo; Sharat Singh

Archive | 2012

DRUG SELECTION FOR CANCER THERAPY BY PROFILING SIGNAL TRANSDUCTION PROTEINS IN ASCITES OR PLEURAL EFFLUX SAMPLES

Sharat Singh; Phillip Kim; Xinjun Liu; Belen Ybarrondo; Limin Liu

Archive | 2015

ANTIBODIES TO MICROBIOME, STRESS FACTORS AND MAST CELL MARKERS AS DIAGNOSTIC MARKERS FOR IBS

Sharat Singh; Ling Nicholas Chi-Kwan; Shui-Long Wang; Fred Princen; Stefan Westin; Steven Lockton

Archive | 2014

METHOD OF THERAPY SELECTION FOR PATIENTS WITH CANCER

Sharat Singh; Anne Kuller; Tani Ann T. Lee; Saswati Hazrar; Richard Kirkland; Xinjun Liu; Phillip Kim

Archive | 2012

DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING ANTIBODY-BASED ARRAYS

Phillip Kim; Sharat Singh

Explore More
Researchain Logo
Decentralizing Knowledge